PEEK-OPTIMA HA Enhanced resulted in greater new bone formation at 6 weeks, and provided a more favorable environment with higher quality local bone at 6 and 12 weeks compared to PEEK-OPTIMA Natural. Bone ongrowth resulted not only on the endplates, but on all faces of the interbody device. 2
BREAKING NEWS – Interbody fusion devices composed of PEEK-OPTIMA HA Enhanced have received FDA 510(k) clearance in the US and CE mark approval in Europe.
Spinal News International explores the potential of Invibio’s PEEK-OPTIMA™ HA Enhanced featuring results from the recent cervical fusion study and discussions with industry leaders.
"We saw the benefits of the PEEK-OPTIMA HA Enhanced material in terms of the interface between the material and the body."
Professor Bill Walsh
Surgical & Orthopaedic Research Laboratories
University of New South Wales
Invibio is a proven partner to medical device manufacturers and a leading provider of biomaterial solutions. Our revolutionary polymers, unsurpassed manufacturing support, and deep device knowledge have enabled device companies around the world to bring innovations to market for over 15 years.